REGENXBIO REPORTS POSITIVE BIOMARKER DATA FROM AFFINITY DUCHENNE® TRIAL OF RGX-202 GENE THERAPY

Stock Information for 2seventy bio Inc.

Loading

Please wait while we load your information from QuoteMedia.